SELL and COVID-19: Although there was no difference in the frequency of CD4+ T-cells, COVID-19 patients presented an increased percentage of CD69+, CD107a+, T-bet+, and PD-1+ along with decreased frequencies of CD28+, CD38+, CD62L− and CD45RO+ CD4+ T-cells as compared to HCs.